IntelliseqS.A.Active

Research and experimental development on biotechnology

KRS: 0000943744 NIP: 6772383205 REGON: 12315870500000

Overview

Registry date
2021-12-31
Share capital
$819,126.01
Activity description

Intelliseq is a company that provides a cloud-based platform for the analysis of Next-Generation Sequencing (NGS) data and clinical interpretation. Their services include automated genomic analysis and reporting through products like iFlow™ and GeneSpect™ Reporters, which cover various medical conditions such as hereditary cancers and cardiovascular diseases. The platform is designed for ease of use, allowing users to perform analyses without needing extensive expertise.

Registered address
Ul. Stanisława Konarskiego 42/13, 30-046 Kraków, Poland
Website
intelliseq.plWebsite active
Electronic delivery address
AE:PL-66195-56580-IIBFF-14

Industry

NameCode
Research and experimental development on biotechnology
72.11.Z
Agents involved in the sale of a variety of goods
46.19.Z
Computer consultancy activities
62.02.Z
Computer facilities management activities
62.03.Z
Other information technology and computer service activities
62.09.Z

Bank accounts

Registered as a VAT taxpayer on 2014-09-30.Active

Authorized Representatives

Ownership

Competitors

NameRevenueWebsite
FcbiotechS.A.$148,945.77fcbiotech.pl
UveraS.A.$155,384.29uvera.eu
PellicarnosS.A.$135,043.43pellicarnos.com
WPD PharmaceuticalsS.A.$87,561.70wpdpharmaceuticals.pl/contact/wpdsa/
DigitmedS.A.$64,087.41digitmed.pl
InventroS.A.$12,176.61inventro.co
Oncotherics PolandS.A.$7,565.33oncotherics.com
ArthecS.A.$6,901.64arthec.eu
4cell TherapiesS.A.$838.644celltherapies.com
UrtesteS.A.$324.85urteste.com

FAQ

Last updated: 2025-12-14